Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.
about
Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical considerations for th ...... hibitors in premature infants.
@en
Clinical considerations for th ...... hibitors in premature infants.
@nl
type
label
Clinical considerations for th ...... hibitors in premature infants.
@en
Clinical considerations for th ...... hibitors in premature infants.
@nl
prefLabel
Clinical considerations for th ...... hibitors in premature infants.
@en
Clinical considerations for th ...... hibitors in premature infants.
@nl
P2860
P1476
Clinical considerations for th ...... hibitors in premature infants.
@en
P2093
Karen E Corff
Kris C Sekar
P2860
P304
P356
10.5863/1551-6776-12.3.147
P577
2007-07-01T00:00:00Z